ED
CBRE icon

Exane Derivatives’s CBRE Group CBRE Stock Holding History

Exane Derivatives’s Portfolio CBRE Stock Details CBRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$442 Sell
6
-38
-86% -$3.06K ﹤0.01% 585
2022
Q1 		$4.03K Hold
44
– – ﹤0.01% 709
2021
Q4 		$4.78K Sell
44
-2,624
-98% -$269K ﹤0.01% 623
2021
Q3 		$260K Buy
2,668
+395
+17% +$36.7K 0.06% 325
2021
Q2 		$189K Buy
2,273
+2,196
+2,852% +$187K 0.04% 419
2021
Q1 		$6.09K Hold
77
– – ﹤0.01% 614
2020
Q4 		$4.83K Hold
77
– – ﹤0.01% 561
2020
Q3 		$3.62K Hold
77
– – ﹤0.01% 528
2020
Q2 		$3.48K Hold
77
– – ﹤0.01% 473
2020
Q1 		$2.9K Hold
77
– – ﹤0.01% 480
2019
Q4 		$4.65K Buy
77
+38
+97% +$2.1K ﹤0.01% 444
2019
Q3 		$2.07K Sell
39
-770
-95% -$40.5K ﹤0.01% 486
2019
Q2 		$41.5K Hold
809
– – 0.01% 400
2019
Q1 		$40K Sell
809
-10,211
-93% -$479K 0.01% 347
2018
Q4 		$441K Buy
11,020
+10,979
+26,778% +$454K 0.08% 185
2018
Q3 		$1.81K Hold
41
– – ﹤0.01% 504
2018
Q2 		$1.96K Hold
41
– – ﹤0.01% 498
2018
Q1 		$1.91K Sell
41
-7
-15% -$319 ﹤0.01% 450
2017
Q4 		$2.08K Sell
48
-172
-78% -$7.13K ﹤0.01% 456
2017
Q3 		$8.33K Sell
220
-12
-5% -$441 ﹤0.01% 409
2017
Q2 		$8.44K Sell
232
-37
-14% -$1.29K ﹤0.01% 406
2017
Q1 		$9.36K Sell
269
-43
-14% -$1.44K ﹤0.01% 353
2016
Q4 		$9.82K Sell
312
-10
-3% -$289 ﹤0.01% 398
2016
Q3 		$9.01K Buy
322
+33
+11% +$942 ﹤0.01% 409
2016
Q2 		$7.65K Buy
289
+74
+34% +$2.16K ﹤0.01% 384
2016
Q1 		$6.2K Hold
215
– – ﹤0.01% 438
2015
Q4 		$7.43K Hold
215
– – ﹤0.01% 349
2015
Q3 		$6.88K Sell
215
-47
-18% -$1.67K ﹤0.01% 373
2015
Q2 		$9.69K Hold
262
– – ﹤0.01% 365
2015
Q1 		$10.1K Sell
262
-567
-68% -$19.6K ﹤0.01% 376
2014
Q4 		$28.4K Buy
+829
New +$26.5K ﹤0.01% 359

Other funds holding CBRE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Exane Derivatives's CBRE Position: Q2 2022 in Review

Exane Derivatives reduced its CBRE Group (CBRE) stake by 86% in Q2 2022, selling an estimated $3.06K and leaving 6 shares worth $442. The position accounts for ﹤0.01% of the portfolio, ranked #585.

Exane Derivatives first reported a position in CBRE in Q4 2014 and has held it in 31 quarters since. The position peaked at $441K in Q4 2018. 698 funds tracked by Wall St. Rank hold CBRE as of Q2 2022.

  • Exane Derivatives held 6 shares of CBRE Group worth $442 as of Q2 2022.
  • Exane Derivatives sold 38 CBRE Group shares in Q2 2022, an estimated $3.06K.
  • CBRE Group made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #585 holding.
  • Exane Derivatives first reported a position in CBRE Group in Q4 2014 and has held it in 31 quarters since.
  • Exane Derivatives's CBRE Group position peaked at $441K in Q4 2018.
  • 698 funds tracked by Wall St. Rank held CBRE Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.